Non-specific immunosuppressants in the treatment of multiple sclerosis
- 8 May 2004
- journal article
- review article
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 106 (3) , 263-269
- https://doi.org/10.1016/j.clineuro.2004.02.012
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Mitoxantrone in progressive multiple sclerosis: a placebo-controlled, double-blind, randomised, multicentre trialThe Lancet, 2002
- Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosisThe Lancet, 1998
- New treatments and azathioprine in multiple sclerosisThe Lancet, 1997
- Intramuscular interferon beta‐1a for disease progression in relapsing multiple sclerosisAnnals of Neurology, 1996
- Copolymer 1 reduces relapse rate and improves disability in relapsing‐remitting multiple sclerosisNeurology, 1995
- Interferon beta‐lb in the treatment of multiple sclerosisNeurology, 1995
- Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosisNeurology, 1993
- Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosisNeurology, 1993
- Overview of azathioprine treatment in multiple sclerosisThe Lancet, 1991
- Placebo-controlled multicentre randomised trial of interferon β-1b in treatment of secondary progressive multiple sclerosisPublished by Elsevier